EDOCAL
Early Detection Of CAncer using photonic crystal Lasers
| Coordinatore | 2M Engineering Limited
Organization address
address: SIDNEY STREET 80 contact info |
| Nazionalità Coordinatore | United Kingdom [UK] |
| Sito del progetto | http://www.edocal.eu |
| Totale costo | 1˙805˙664 € |
| EC contributo | 1˙448˙715 € |
| Programma | FP7-SME
Specific Programme "Capacities": Research for the benefit of SMEs |
| Code Call | FP7-SME-2008-1 |
| Funding Scheme | BSG-SME |
| Anno di inizio | 2010 |
| Periodo (anno-mese-giorno) | 2010-01-01 - 2011-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
2M Engineering Limited
Organization address
address: SIDNEY STREET 80 contact info |
UK (FOLKSTONE) | coordinator | 1˙184˙715.00 |
| 2 |
COMPOUND SEMICONDUCTOR TECHNOLOGIES GLOBAL LIMITED
Organization address
address: "Block 6, West of Scotland Science Park, Maryhill Road" contact info |
UK (Glasgow) | participant | 102˙000.00 |
| 3 |
TOP-GAN SP ZOO
Organization address
address: UL. SOKOLOWSKA 29/37 contact info |
PL (WARSZAWA) | participant | 80˙000.00 |
| 4 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam
Organization address
address: MEIBERGDREEF 9 contact info |
NL (AMSTERDAM) | participant | 41˙000.00 |
| 5 |
Tayside Health Board
Organization address
address: "Kings Cross, Clepington Road" contact info |
UK (Dundee) | participant | 41˙000.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'In Europe there are 3 million new cancer cases per year. According to the WHO the burden of cancer can be reduced by systematic and equitable implementation of evidence based strategies for cancer prevention, early detection and management of patients with cancer. 33% of the cancer burden could be reduced if detected early and treated adequately. The WHO concludes that, early diagnosis of cancers could save the developed world an average of €40 billion per year on medical costs and €80 billion per year on realized productivity. The direct savings on medical treatment alone would be more than €10.000 per patient if early detection was possible. Early cancer diagnosis today consists of recognition of some of the ‘early’ signs by the patient themselves or detection from screenings carried out on specific population groups. If something suspicious is found the next step is to perform a blood analysis and/or to look with non-invasive imaging techniques. Current imaging techniques are widely used in diagnostic procedures but they cannot give conclusive evidence of cancer. Today, only a biopsy and the subsequent pathologist’s interpretation can give a definitive diagnosis of cancer and this is not always enough EDOCAL will use a tunable blue laser to selectively excite an accumulated photo sensitizer, called proto-porphyrin. This sensitizer is taken by the patient to enhance contrast between healthy and cancerous tissue. Reflected light is filtered using state of the art ultra narrow photonic crystal technology. Initial studies have shown that it is possible to detect cancerous tissue using blue light in combination with FDA approved sensitizers (ALA-5 and Proto-Porphyrin). This tool will be based on the principle of preferential retention of proto-porphyrin by cancer cells. The purpose of this project is to create a breakthrough tool for early cancer detection by combining state of the art laser and imaging technology with leading medical research.'
Introduzione (Teaser)
Early detection of cancer saves lives, improves quality of life and reduces health care cost. According to the World Health Organisation the burden of cancer can be significantly reduced by implementation of evidence based strategies for prevention, early detection and management of patients with cancer.